Tannin Capital’s Edwards Lifesciences EW Stock Holding History

Tannin Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$450K	Sell	4,976 -582	-10%	-$48.8K	0.3%	92
2026 Q1	$445K	Buy	+5,558	New	+$458K	0.32%	83

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Tannin Capital's EW Position: Q2 2026 in Review

Tannin Capital reduced its Edwards Lifesciences (EW) stake by 10% in Q2 2026, selling an estimated $48.8K and leaving 4,976 shares worth $450K. The position accounts for 0.3% of the portfolio, ranked #92.

Tannin Capital first reported a position in EW in Q1 2026 and has held it in 2 quarters since. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Tannin Capital held 4,976 shares of Edwards Lifesciences worth $450K as of Q2 2026.
Tannin Capital sold 582 Edwards Lifesciences shares in Q2 2026, an estimated $48.8K.
Edwards Lifesciences made up 0.3% of Tannin Capital's portfolio in Q2 2026, its #92 holding.
Tannin Capital first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 2 quarters since.
1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Tannin Capital's 13F filing for Q2 2026, filed 4 Aug 2026.